Mitochondria and human immunodefiency virus type 1
AssigneeNew York University
InventorsSylvia Lee-Huang, Paul Huang, Philip Huang
Life of this patent
Estimating the term…
Abstract
Methods described herein relate to mitochondria and their role in Human immunodeficiency virus type 1 (HIV-1) infection and cell-to-cell HIV-1 transmission and compositions and methods for modulating mitochondrial mediated cell-to-cell transmission of HIV-1. Methods for screening to identify inhibitors of mitochondrial mediated cell-to-cell transmission of HIV-1 are also envisioned herein.
Claims10
A method for screening to identify a compound with anti-human immunodeficiency virus type 1 (HIV-1) activity, the method comprising:
- (1) contacting HIV-1 infected cells and target cells with a candidate compound, wherein the target cells are susceptible to HIV-1 infection;
- and
- (2) measuring cell-to-cell transmission of HIV-1 in the presence and absence of the candidate compound,
- wherein cell-to-cell transmission of HIV-1 is measured by tracking mitochondrial movement from the HIV-1 infected cells to the target cells, and a reduction in mitochondrial movement from the HIV-1 infected cells to the target cells in the presence of the candidate compound relative to the absence of the candidate compound indicates that the candidate compound is an inhibitor of cell-to-cell HIV-1 transmission.
A method for screening to identify a compound that blocks human immunodeficiency virus type 1 (HIV-1) transmission, the method comprising:
- (1) providing mitochondria purified from HIV-1 infected cells;
- (2) contacting the mitochondria purified from HIV-1 infected cells and target cells with a candidate compound, wherein the target cells are susceptible to HIV-1 infection;
- and
- (3) measuring transmission of HIV-1 from the mitochondria to the target cells in the presence and absence of the candidate compound, wherein a reduction in transmission of HIV-1 in the presence of the candidate compound relative to the absence of the candidate compound indicates that the candidate compound is an inhibitor of mitochondria-mediated HIV-1 transmission.
Dependencies are inferred from the claim text.